During the Omicron Pandemic Wave, the Severe Systemic Inflammatory Status of COVID-19 Indicated a Higher Risk of In-Hospital Mortality and Mediated the Clinical Efficacy of Corticosteroids.

Yu CaoYing HanJiangping WuJianping SunYanchao DaiGuifang QiaoKang LiAng LiYonghong ZhangYingmin MaQing-Kun Song

Published in: Infection and drug resistance (2023)

Systemic inflammatory indicators had good diagnostic performance for in-hospital mortality. Patients with severe systemic inflammatory status should not receive corticosteroid treatment and further studies are warranted for confirmation.

Keyphrases

coronavirus disease
sars cov
oxidative stress
early onset
drug induced
combination therapy
case control